Law Office of Brodsky & Smith, LLC Announces Investigation of BioClinica, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of BioClinica, Inc.

PR Newswire

BALA CYNWYD, Pa., Jan. 30, 2013

BALA CYNWYD, Pa., Jan. 30, 2013 /PRNewswire/ -- Law office of Brodsky & Smith,
LLC announces that it is investigating potential claims against the Board of
Directors of BioClinica, Inc. ("BioClinica" or the "Company") (Nasdaq: BIOC)
relating to the acquisition by a holding company controlled by JLL Partners,
Inc. ("JLL").

Under the terms of the transaction, BioClinica shareholders will receive only
$7.25 in cash for each share of BioClinica stock they own. The investigation
concerns possible breaches of fiduciary duty and other violations of state law
by the Board of Directors of BioClinica for not acting in the Company's
shareholders' best interests in connection with sale process to JLL. The
transaction may undervalue the Company as an analyst has set a $9.00 per share
price target on BioClinica stock.

If you own shares of BioClinica stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC,
Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/534-bioc-bioclinica-inc.html, by calling toll free
877-LEGAL-90.

SOURCE Brodsky & Smith, LLC

Website: http://www.brodsky-smith.com